webleads-tracker

|
ImaBiotech website in English
|
  

News

  • ASMS 2017

    Come and meet Rima Ait-Belkacem and Jonathan Stauber to discover all our capabilities. June 4- 8, 2017, in (...)

    Read more
  • Webinar on Immuno-Oncology by Rima AIT-BELKACEM, PhD

    The webinar titled “Immuno-Oncology: Tryptophan-Kynurenine Microenvironment Tumor Metabolites Pathway Highlighted by (...)

    Read more
See all news

Company

Innovation dedicated to patients

Localized in USA, Europe and Asia, ImaBiotech is a Contract Research Organization (CRO) company which supports pharmaceutical compagnies with innovative services from preclinical to clinical stages. ImaBiotech is specialized in a new technology called Mass Spectrometry Imaging which improves Target Engagement, Pharmacokinetics, pharmacodynamics and support of toxicology studies.

Founded by a team of experts in Mass Spectrometry and MALDI Imaging Mass Spectrometry (MALDI imaging), ImaBiotech offers services and software in the healthcare field in order to accelerate the launch of medications on the market, and to strengthen the precision and applications for new medical diagnostic tools.


Jonathan Stauber PhD

Voir le profil de Jonathan Stauber sur LinkedIn Voir le profil de David Bonnel sur LinkedIn Voir le profil de Alain Héron  sur LinkedIn Voir le profil de Stefan Linehan sur LinkedIn

Imabiotech commercial

Voir le profil de Florian Farcette sur LinkedIn Voir le profil de Charles Larson sur LinkedIn